Premium
Gold‐Coated Fe 3 O 4 Nanoroses with Five Unique Functions for Cancer Cell Targeting, Imaging, and Therapy
Author(s) -
Li Chunmei,
Chen Tao,
Ocsoy Ismail,
Zhu Guizhi,
Yasun Emir,
You Mingxu,
Wu Cuichen,
Zheng Jing,
Song Erqun,
Huang Cheng Zhi,
Tan Weihong
Publication year - 2014
Publication title -
advanced functional materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.069
H-Index - 322
eISSN - 1616-3028
pISSN - 1616-301X
DOI - 10.1002/adfm.201301659
Subject(s) - photothermal therapy , aptamer , materials science , doxorubicin , drug delivery , magnetic resonance imaging , nanotechnology , fluorescence lifetime imaging microscopy , cancer therapy , molecular imaging , nanomaterials , medical imaging , biomedical engineering , fluorescence , cancer , chemotherapy , optics , medicine , in vivo , radiology , genetics , surgery , physics , microbiology and biotechnology , biology
The development of nanomaterials that combine diagnostic and therapeutic functions within a single nanoplatform is extremely important for molecular medicine. Molecular imaging with simultaneous diagnosis and therapy will provide the multimodality needed for accurate diagnosis and targeted therapy. Here, gold‐coated iron oxide (Fe 3 O 4 @Au) nanoroses with five distinct functions are demonstrated, integrating aptamer‐based targeting, magnetic resonance imaging (MRI), optical imaging, photothermal therapy. and chemotherapy into one single probe. The inner Fe 3 O 4 core functions as an MRI agent, while the photothermal effect is achieved through near‐infrared absorption by the gold shell, causing a rapid rise in temperature and also resulting in a facilitated release of the anticancer drug doxorubicin carried by the nanoroses. Where the doxorubicin is released, it is monitored by its fluorescence. Aptamers immobilized on the surfaces of the nanoroses enable efficient and selective drug delivery, imaging, and photothermal effect with high specificity. The five‐function‐embedded nanoroses show great advantages in multimodality.